ZOLL Lifevest Wearable Defibrillator To Be Showcased At American Association Of Heart Failure Nurses Annual Meeting 2012
Chelmsford, MA - ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced recently that it will display the LifeVest Wearable Defibrillator in Booth #209 at the American Association of Heart Failure Nurses (AAHFN) Annual Meeting being held from June 28-30 in Chicago.
An estimated 5.7 million Americans are currently living with heart failure, and an additional 670,000 new cases are diagnosed annually, up from 500,000 a few years ago. The risk of sudden cardiac death following a myocardial infarction is the highest in the first 30 days, and patients with heart failure following myocardial infarction are at 4-6 times greater risk.
The LifeVest Wearable Defibrillator is worn by patients at risk for sudden cardiac arrest (SCA), providing protection during their changing medical condition, and until their permanent risk of SCA is established. The LifeVest protects these patients during this time of highest risk while they are being optimized on medical therapy. A patient’s condition can improve from the benefits of medical therapy, including meaningful improvement to the amount of ejection fraction. However, medical therapy and stabilization can take up to three months or more, which is why wearing a LifeVest is so important.
The LifeVest is lightweight and easy to wear, allowing patients to return to their activities of daily living, while having the peace of mind that they are protected from SCA. The LifeVest continuously monitors the patient’s heart and, if a life-threatening heart rhythm is detected, the device delivers a treatment shock to restore normal heart rhythm.
The LifeVest is used for a wide range of patient conditions or situations, including following a heart attack, before or after bypass surgery or stent placement, as well as for those with cardiomyopathy or congestive heart failure that places them at particular risk.
The LifeVest is covered by most health plans in the United States, including commercial, state, and federal plans.
For more information, go to www.zoll.com .
SOURCE: ZOLL Medical Corporation